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PRIMARY MELANOMA OF MECKEL’S CAVE
Case report 
Asdrubal Falavigna1, Luis A. B. Borba2, Fernando Antonio Patriani Ferraz3,
Giovana Camargo de Almeida4, José Valentim Krindges Júnior 4
ABSTRACT - We present a case of trigeminal neuralgia with cranial normal magnetic resonance image (MRI) and computed tomog-
raphy.The pain was not relieved by carbamazepine and microvascular decompression surgery was done.After two months the pain
was similar to the condition before surgery. At this time, MRI showed an expansive lesion in Meckel’s cave that was treated with
radical resection by extra-dural approach. The pathologic examination revealed a primary melanoma. The follow-up after six
months did not show abnormalities.
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Melanoma primário do cavo de Meckel: relato de caso
RESUMO - Apresentamos um caso de neuralgia do trigêmeo com investigação radiológica de ressonância magnética (RM) e tomo-
grafia computadorizada apresentando resultado normal.A dor não apresentou alívio com carbamazepina, sendo indicado descom-
pressão microvascular do trigêmio. Passados dois meses, o paciente queixava-se de dor com intensidade similar à do pré-oper-
atório. Nova RM mostrou lesão expansiva no cavo de Meckel, a qual foi tratada cirurgicamente por abordagem extra-dural. O exame
anatomopatológico foi compatível com melanoma primário. O seguimento radiológico, após seis meses da cirurgia, não apresen-
tou anormalidades.
PALAVRAS-CHAVE: melanoma primário, sistema nervoso central, cavo de Meckel, carbamazepina.
The central nervous system (CNS) is host to a wide vari-
ety of melanocytic neoplasms including the common metasta-
tic malignant melanoma and the relatively benign, as well as
overtly malignant, primary neoplasms of leptomeningeal
melanocyte1. Metastases of malignant melanomas in the CNS
are fairly common; their incidence is approximately 5-10% of
all tumors metastatizing to the CNS. In contrast, primary
melanomas of the CNS are a rare occurrence2,3.Trigeminal neu-
ralgia is often the first complaint for a tumor of the Gasserian
ganglion. Tumors of the fifth nerve in general are extremely
rare and comprise 0.2 % of all primary and secondary intra-
cranial neoplasms4. Melanomas of the fifth nerve are even rar-
er5,6.
We report a case of trigeminal neuralgia that was not
relieved by carbamazepine and microvascular decompression.
The expansive lesion was detected in Meckel´s cave only after
a second magnetic resonance image (MRI) and the
histopathological examination showed a primary melanoma.
CASE
A 55-year old man, smoker, complains of right trigeminal neu-
ralgia that began 4 months ago. The neurological examination was
normal and treatment was instituted with carbamazepine 600mg a
day.The neurological investigation was performed by cranial MRI and
computed tomography (CT).After 30 days the patient returned with-
out relief of the facial pain and with a normal neuroradiological
examination (Fig. 1A). Microvascular decompression was indicated
with displacement of the vessel impinging on nerve. The pain relief
was temporary. After 60 days the pain was similar to the conditions
before surgery and carbamazepine dose was increased to 1000 mg
a day CT  showed only the area of surgical manipulation (Fig. 1B).
Despite the increased carbamazepine dose, the pain was more in-
tense and frequent. Another MRI  showed an expansive lesion in the
right Meckel’s cave, hyperintense in T1 with homogenous contrast
(Fig. 2A, B). Radical surgical excision was performed by extradural
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Fig 1. Normal neuroradiological investigation.  Post contrast T1-weighted axial MRI scan (1A) and axial CT (1B).
The CT was done after the microvascular decompression surgery.
Fig 2. Post contrast T1-weighted axial (2A) and coronal (2B) MRI scans showing expansive lesion at the right Meckels cave and the radical excision after surgery
demonstrated by axial CT (2C).
Fig 3. Malignant tumor with cellular pleomorphism and the presence of melanocytic cells.  Photomicrographs illustrating histological features. H & E, original
magnification, X 100 (3A) and X 400 (3B).
approach (Fig. 2C).After surgery there was right facial anesthesia and
the trigeminal pain was relieved.The histopathological exam revea-
led a malignant tumor with cellular pleomorphism and the presence
of melanocytic cells (Fig. 3). Skin was normal at inspection. Radiological
examinations of the chest and abdomen failed to detect any other
lesions. The 9-month radiological follow-up did not detect tumor
recurrence.
DISCUSSION
Primary melanocytic tumors occur both as diffuse lep-
tomeningeal proliferations and discrete expansive lesions.
These tumors consist of a spectrum ranging from well-differ-
entiated melanocytomas to melanoma1. Patients of all ages
are affected. Diffuse lesions, which usually affect children, are
occasionally associated with multiple or extensive pigment-
ed lesions of the skin. This complex is known as neurocuta-
neous melanosis1.
Melanoma can arise anywhere melanoblasts are found,
and it has been suggested that dural melanoma originates from
heterotrophic dural melanocytes. In the cranialspinal axis,
melanocytes are most frequent in the leptomeninges that
occur predominantly around the ventral and lateral aspects
of the spinal cord, the ventral aspect of the brain, cerebral
peduncles, and sylvian fissure7,-10. While some degree of lep-
tomeningeal melanosis occurs in up to 85% of the population,
heterotrophic melanin detected in the dura is rare11. Reports
of primary dural melanoma are rare12-18 and tumors of the fifth
nerve in general are extremely rare and comprise 0.2 % of all
primary and secondary intra-cranial neoplasms4. Melanomas
of the fifth nerve are even rarer5,6. In von Recklinghausen’s dis-
ease, primary malignant melanomas have been described on
the skin as well as in the uvea19- 21, iris22 and meninges23-25; none
have been reported to involve the fifth nerve as far as we know.
An interesting observation was that carbamazepine asso-
ciated with microvascular decompression did not relieve the
trigeminal pain. This should call attention to the fact that it is
necessary to persist with the radiological investigation.
Meningeomas and schwannomas of the region of Meckel’s
cave are not uncommon. Their CT appearance may be similar
to ours except that,on plain CT scan,melanomas usually appear
hyperdense26.
Primary malignant melanomas of the CNS vary in cytolog-
ic features much like those at other sites. Mitosis ranges from
scant to numerous. Necrosis may be extensive, producing
perivascular pseudopapillae. Transition to a diffuse growth
pattern, satellite nodule formation in surrounding meninges
and irregular invasion of spinal cord substance is common in
melanoma1. In immunohistochemistry, melanocytic tumors
are vimentin-reactive but lack epithelial markers. Staining for
S-100 protein varies, but is often strong.Though not melanoma-
specific, the HMB-45 stain is usually positive1.
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It appears that primary dural melanoma follows a less
aggressive course, patients surviving longer than those with
leptomeningeal melanoma18,27. A review on leptomeningeal
melanoma showed a median postoperative survival of 1 month
and an overall 2-year survival of only 15%28. Patients treated
surgically for primary dural melanoma fare somewhat better,
with disease-free intervals ranging from 9 to 18 months12,13,18.
Adjuvant radiotherapy was not prescribed because of a pauci-
ty of evidence to suggest any benefit13,29,30.
Our case is a rare example of a primary melanocytic tumor
of the fifth cranial nerve.We considered the melanoma in our
case as primary because, there was no evidence of any other
melanoma on the skin or in the eye, there were no associat-
ed giant hairy nevi and imaging screening failed to reveal any
extra-cranial malignancy.
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